Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal Carcinoma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study aims to explore the efficacy and safety of risk-adapted adjuvant therapy based on dynamic EBV-DNA changes and MRI in nasopharyngeal carcinoma patients.
Epistemonikos ID: f212335533e7aea900c4621fa4ca6d4a2eeb4c77
First added on: Aug 14, 2026